← Back to Search

Device

Right sided device for Cardiogenic Shock

N/A
Recruiting
Research Sponsored by Abiomed Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from hospital admission until hospital discharge, average 5 days
Awards & highlights

Study Summary

The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.

Eligible Conditions
  • Cardiogenic Shock
  • Percutaneous Coronary Intervention

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from hospital admission until hospital discharge, average 5 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and from hospital admission until hospital discharge, average 5 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Endpoint Left Sided Impella
Primary Endpoint Right Sided Impella

Trial Design

2Treatment groups
Experimental Treatment
Group I: Right sided deviceExperimental Treatment1 Intervention
All patients implanted with a right sided support Impella device -this includes the Impella RP
Group II: Left sided deviceExperimental Treatment1 Intervention
All patients implanted with a left sided support Impella device - this includes but is not limited to Impella 2.5, Impella CP, Impella 5.0, Impella 5.5.

Find a Location

Who is running the clinical trial?

Abiomed Inc.Lead Sponsor
41 Previous Clinical Trials
34,225 Total Patients Enrolled
Amin Medjamia, MDStudy DirectorAbiomed Inc.
1 Previous Clinical Trials
1,000 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~141 spots leftby Apr 2025